MEP6808A - Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 - Google Patents

Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Info

Publication number
MEP6808A
MEP6808A MEP-68/08A MEP6808A MEP6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A
Authority
ME
Montenegro
Prior art keywords
piperidinoylpyrrolidines
receptor agonist
melanocortin
melanocortin type
type
Prior art date
Application number
MEP-68/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Anette Graven Sams
Mogens Larsen
Gitte Mikkelsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP6808A publication Critical patent/MEP6808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MEP-68/08A 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 MEP6808A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77629506P 2006-02-23 2006-02-23
US88784007P 2007-02-02 2007-02-02
PCT/IB2007/000456 WO2007096763A2 (fr) 2006-02-23 2007-02-19 Pipéridinoylpyrrolidines en tant qu'agonistes du récepteur de la mélanocortine de type 4

Publications (1)

Publication Number Publication Date
MEP6808A true MEP6808A (xx) 2010-02-10

Family

ID=38169450

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-68/08A MEP6808A (xx) 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Country Status (22)

Country Link
US (1) US8138188B2 (fr)
EP (1) EP1989196B1 (fr)
KR (1) KR101036981B1 (fr)
AP (1) AP2008004602A0 (fr)
AU (1) AU2007219236B2 (fr)
BR (1) BRPI0708264A2 (fr)
CA (1) CA2642922C (fr)
CR (1) CR10219A (fr)
DK (1) DK1989196T3 (fr)
EA (1) EA200801738A1 (fr)
EC (1) ECSP088688A (fr)
ES (1) ES2402581T3 (fr)
HK (1) HK1126489A1 (fr)
IL (1) IL193279A (fr)
MA (1) MA30228B1 (fr)
ME (1) MEP6808A (fr)
MX (1) MX2008010899A (fr)
NO (1) NO20083480L (fr)
RS (1) RS20080371A (fr)
SG (1) SG185849A1 (fr)
TN (1) TNSN08337A1 (fr)
WO (1) WO2007096763A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019100A1 (fr) * 2007-07-19 2009-01-28 Santhera Pharmaceuticals (Schweiz) AG Dérivés substitués d'hétéroarylpipéridine en tant que modulateurs du récepteur de la mélanocortine-4
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
US8902867B2 (en) 2007-11-16 2014-12-02 Qualcomm Incorporated Favoring access points in wireless communications
US8737295B2 (en) 2007-11-16 2014-05-27 Qualcomm Incorporated Sector identification using sector parameters signatures
US9603062B2 (en) 2007-11-16 2017-03-21 Qualcomm Incorporated Classifying access points using pilot identifiers
US8848656B2 (en) 2007-11-16 2014-09-30 Qualcomm Incorporated Utilizing broadcast signals to convey restricted association information
EP2103614A1 (fr) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Dérivés d'imidazopyrimidine, d'imidazopyrazine et d' imidazopyridazine substitués en tant que modulateur de récepteur de la mélanocortine-4
US8588773B2 (en) 2008-08-04 2013-11-19 Qualcomm Incorporated System and method for cell search and selection in a wireless communication system
UA99555C2 (en) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Melanocortin receptor agonists
EP2722045B1 (fr) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions pour traiter les nausées et vomissements à médiation centrale
PE20121483A1 (es) * 2009-11-18 2012-12-02 Helsinn Healthcare Sa Composiciones para tratar nausea y vomito centralmente mediados
WO2012120054A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683704B1 (fr) 2011-03-08 2014-12-17 Sanofi Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
EP2683699B1 (fr) 2011-03-08 2015-06-24 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
PL3333165T3 (pl) 2015-08-04 2019-12-31 Astellas Pharma Inc. Pochodne piperazyny
BR112022024527A2 (pt) 2020-06-09 2022-12-27 Pfizer Compostos de espiro como antagonistas do receptor de melanocortina 4 e usos dos mesmos
WO2023105387A1 (fr) 2021-12-06 2023-06-15 Pfizer Inc. Antagonistes du récepteur 4 de la mélanocortine et leurs utilisations

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5274143A (en) * 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2098167C (fr) * 1992-06-24 2006-12-19 Dorothea Isler Aliments pour humains et animaux contenant un inhibiteur de la lipase
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
ATE198889T1 (de) * 1994-10-27 2001-02-15 Janssen Pharmaceutica Nv Apolipoprotein-b syntheseinhibitoren
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
WO2000035296A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Liberation amelioree d'agents medicamenteux actifs par un enrobage de chewing-gum
KR100652994B1 (ko) * 1998-09-11 2006-11-30 아방티 파르마 소시에테 아노님 아제티딘 유도체, 이의 제조방법 및 이를 함유하는 약제
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
CA2431800C (fr) 2000-12-14 2014-07-08 Amylin Pharmaceuticals, Inc. Peptide yy et antagonistes de peptides yy destines au traitement des troubles du metabolisme
GEP20053710B (en) * 2001-02-28 2005-12-26 Merck & Co Inc Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
US7015235B2 (en) 2001-02-28 2006-03-21 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
NZ524633A (en) 2001-03-22 2005-02-25 Solvay Pharmaceuticals B 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
CA2461454A1 (fr) 2001-09-24 2003-04-03 Oregon Health And Science University Evaluations des neurones dans le noyau arque pour le criblage d'agents de modification du comportement alimentaire
AU2003219934A1 (en) 2002-03-06 2003-09-22 Merck And Co., Inc. Method of treatment or prevention of obesity
ES2301833T3 (es) 2002-07-29 2008-07-01 Hoffmann La Roche Derivados de benzodioxol.
US7091216B2 (en) 2002-08-02 2006-08-15 Merck & Co., Inc. Substituted furo[2,3-b]pyridine derivatives
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
GB0402492D0 (en) * 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
CA2617654A1 (fr) * 2005-08-04 2007-02-08 Pfizer Limited Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
EP2326638B9 (fr) 2008-08-06 2013-11-13 Pfizer Limited Composés diazépines et diazocanes en tant qu'agonistes de mc4

Also Published As

Publication number Publication date
NO20083480L (no) 2008-09-10
TNSN08337A1 (fr) 2009-12-29
MA30228B1 (fr) 2009-02-02
WO2007096763A2 (fr) 2007-08-30
AU2007219236A1 (en) 2007-08-30
SG185849A1 (en) 2012-12-28
CA2642922C (fr) 2011-08-02
EP1989196B1 (fr) 2013-02-13
ES2402581T3 (es) 2013-05-06
ECSP088688A (es) 2008-10-31
IL193279A (en) 2012-12-31
WO2007096763A3 (fr) 2007-10-18
BRPI0708264A2 (pt) 2011-05-24
EP1989196A2 (fr) 2008-11-12
IL193279A0 (en) 2009-02-11
HK1126489A1 (en) 2009-09-04
RS20080371A (en) 2009-07-15
KR101036981B1 (ko) 2011-05-25
KR20080095918A (ko) 2008-10-29
AU2007219236B2 (en) 2012-06-21
US8138188B2 (en) 2012-03-20
MX2008010899A (es) 2008-11-27
CR10219A (es) 2008-09-23
CA2642922A1 (fr) 2007-08-30
US20090036459A1 (en) 2009-02-05
AP2008004602A0 (en) 2008-10-31
EA200801738A1 (ru) 2008-12-30
DK1989196T3 (da) 2013-04-15

Similar Documents

Publication Publication Date Title
MEP6808A (xx) Priperidinoilpirodolini agonisti receptora menalokortina tipa 4
UA84208C2 (en) Tetraazabenzo(e)azulene derivatives and analogs thereof
GB0625648D0 (en) Compounds
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
MX2009008159A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
TW200732313A (en) Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
MY148470A (en) Indole derivatives as s1p1 receptor agonists
ATE455110T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
JO2686B1 (en) Vehicles
ATE472542T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
MX2008012400A (es) Azolopirimidinas como inhibidores de actividad de cannabinoide 1.
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
TW200640863A (en) Compounds which potentiate glutamate receptor and uses thereof in medicine
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
HK1129226A1 (fr)
GB0621805D0 (en) Organic compounds
MX2007010572A (es) Compuestos de cinolina y su uso como moduladores de receptor x de higado.
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique
DE602007007934D1 (en) Imidazoazephinonverbindungen
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors
UA102508C2 (ru) Производные индола как агонисты рецептора s1p1
TW200716090A (en) Inhibitors of soluble adenylate cyclase
UA89846C2 (ru) Производные карбоксамида как антагонисты мускариновых рецепторов
JO2569B1 (en) Unprecedented pyrazoloperimidones and their uses to inhibit phosphodiesterase